These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 56790)

  • 1. [Control system for basophil cells, mast cells, and lymphocytes].
    Naess K
    Tidsskr Nor Laegeforen; 1976 Mar; 96(7):458-9. PubMed ID: 56790
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic and nonimmunologic generation of superoxide from mast cells and basophils.
    Henderson WR; Kaliner M
    J Clin Invest; 1978 Jan; 61(1):187-96. PubMed ID: 73548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histamine Release from Mast Cells and Basophils.
    Borriello F; Iannone R; Marone G
    Handb Exp Pharmacol; 2017; 241():121-139. PubMed ID: 28332048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation and function in basophil-mast cell system--release mechanism of chemical mediators and their roles.
    Tanizaki Y
    Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1964-71. PubMed ID: 2425534
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate.
    Peachell PT; MacGlashan DW; Lichtenstein LM; Schleimer RP
    J Immunol; 1988 Jan; 140(2):571-9. PubMed ID: 2447182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The reactivity of dispersed human lung mast cells and peripheral blood basophils to acetylcholine].
    Takahashi K; Soda R; Kishimoto T; Matsuoka T; Maeda M; Araki M; Tanimoto Y; Kawada N; Kimura I; Komagoe H
    Arerugi; 1992 Jun; 41(6):686-92. PubMed ID: 1280085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
    Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
    J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mononuclear cell derived histamine releasing factor (HRF) in asthmatic patients. Histamine release from basophils in vitro.
    Alam R; Rozniecki J; Salmaj K
    Ann Allergy; 1984 Jul; 53(1):66-9. PubMed ID: 6204562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies with purified human basophils and mast cells.
    Lichtenstein LM; Schleimer RP; Peters SP; Kagey-Sobotka A; Adkinson NF; Adams GK; Schulman ES; MacGlashan DW
    Monogr Allergy; 1983; 18():259-64. PubMed ID: 6196631
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of H1 and H2 receptor blockers on immunological and nonspecific histamine release from isolated target cells.
    Hofman J; Siergiejko Z; Kuczewska B; Chyrek-Borowska S
    Arch Immunol Ther Exp (Warsz); 1984; 32(5):599-604. PubMed ID: 6085468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding characteristics of human IgE receptors and initial triggering events in human mast cells for histamine release.
    Ishizaka T; Conrad DH
    Monogr Allergy; 1983; 18():14-24. PubMed ID: 6196621
    [No Abstract]   [Full Text] [Related]  

  • 12. SRS-A of rat basophil leukemia cells and rat mast cells.
    Parker CW
    Kroc Found Ser; 1981; 14():23-36. PubMed ID: 6947073
    [No Abstract]   [Full Text] [Related]  

  • 13. Oscillations in free cytosolic calcium during IgE-mediated stimulation distinguish human basophils from human mast cells.
    MacGlashan D; Guo CB
    J Immunol; 1991 Oct; 147(7):2259-69. PubMed ID: 1918962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers of mast cell degranulation.
    Hogan AD; Schwartz LB
    Methods; 1997 Sep; 13(1):43-52. PubMed ID: 9281467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human IgE+ and IgE- are not equivalent to mouse highly cytokinergic IgE.
    Xie L; Schroeder JT; Langdon JM; Sora-Scott RS; Kawakami T; MacDonald SM
    J Allergy Clin Immunol; 2008 Apr; 121(4):1027-33. PubMed ID: 18234322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dental amalgam and its components of histamine release from human basophils and tissue mast cells.
    Schedle A; Samorapoompichit P; Ghannadan M; Franz A; Sperr WR; Sperr W; Valent P
    Wien Klin Wochenschr; 1998 Jul; 110(13-14):467-72. PubMed ID: 9746959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins.
    Zheutlin LM; Ackerman SJ; Gleich GJ; Thomas LL
    J Immunol; 1984 Oct; 133(4):2180-5. PubMed ID: 6206154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils.
    Zuberbier T; Chong SU; Grunow K; Guhl S; Welker P; Grassberger M; Henz BM
    J Allergy Clin Immunol; 2001 Aug; 108(2):275-80. PubMed ID: 11496246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On a mechanism of histamine-liberating effect of radiocontrast media].
    Sergeev PV; Napolov IuK; Shimanovskiĭ NL
    Biull Eksp Biol Med; 1996 Nov; 122(11):512-7. PubMed ID: 8998339
    [No Abstract]   [Full Text] [Related]  

  • 20. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release.
    Stellato C; Cirillo R; de Paulis A; Casolaro V; Patella V; Mastronardi P; Mazzarella B; Marone G
    Anesthesiology; 1992 Nov; 77(5):932-40. PubMed ID: 1280014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.